image-pro plus software (version 6.0 Search Results


94
Bio-Rad image pro plus 6 0 software
Image Pro Plus 6 0 Software, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/image pro plus 6 0 software/product/Bio-Rad
Average 94 stars, based on 1 article reviews
image pro plus 6 0 software - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Bruker Corporation vivo ms fx pro
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Vivo Ms Fx Pro, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vivo ms fx pro/product/Bruker Corporation
Average 90 stars, based on 1 article reviews
vivo ms fx pro - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

99
Bio-Rad image analysis software image pro plus ipp 6 0
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Image Analysis Software Image Pro Plus Ipp 6 0, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/image analysis software image pro plus ipp 6 0/product/Bio-Rad
Average 99 stars, based on 1 article reviews
image analysis software image pro plus ipp 6 0 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism5
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Graphpad Prism5, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism5/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Roper Technologies image-pro plus v4.5 software
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Image Pro Plus V4.5 Software, supplied by Roper Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/image-pro plus v4.5 software/product/Roper Technologies
Average 90 stars, based on 1 article reviews
image-pro plus v4.5 software - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
wavemetrics inc igor pro living image software
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Igor Pro Living Image Software, supplied by wavemetrics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igor pro living image software/product/wavemetrics inc
Average 90 stars, based on 1 article reviews
igor pro living image software - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Caliper Life Sciences living image 2.60.1
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Living Image 2.60.1, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/living image 2.60.1/product/Caliper Life Sciences
Average 90 stars, based on 1 article reviews
living image 2.60.1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
HTC Corporation vive pro eye head-mounted display
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Vive Pro Eye Head Mounted Display, supplied by HTC Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vive pro eye head-mounted display/product/HTC Corporation
Average 90 stars, based on 1 article reviews
vive pro eye head-mounted display - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Caliper Life Sciences igor pro living image 2.60.1
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Igor Pro Living Image 2.60.1, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igor pro living image 2.60.1/product/Caliper Life Sciences
Average 90 stars, based on 1 article reviews
igor pro living image 2.60.1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism 5.0
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Graphpad Prism 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism 5.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism 5.0 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism 8.3
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Graphpad Prism 8.3, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism 8.3/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism 8.3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Nikon coolsnap-pro color camera
RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in <t>vivo</t> following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX <t>Pro</t> <t>optical</t> <t>imaging</t> <t>system</t> and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01
Coolsnap Pro Color Camera, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/coolsnap-pro color camera/product/Nikon
Average 90 stars, based on 1 article reviews
coolsnap-pro color camera - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in vivo following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX Pro optical imaging system and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01

Journal: Acta Neuropathologica Communications

Article Title: Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice

doi: 10.1186/s40478-021-01147-0

Figure Lengend Snippet: RN2N IgG2a treated mice demonstrate an increased disinhibition-like behaviour following passive immunization of pR5 mice. a RN2N IgG isotype does not affect brain delivery in vivo following intravenous administration of Alexa-Fluor 647-conjugated RN2N. Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX Pro optical imaging system and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice. Schematic of EPM arena with its open and closed arms. Mean positional heat map within the EPM for each treatment group and quantification of % time spent in open arms over the duration of the test ( n = 10 for each group). d Percentage (%) weight gain of treatment groups from start of treatment compared to end of treatment ( n = 10 for each group). e – g Activity monitor (open field) showing no differences in treatment groups in e time spent in the centre zone, f resting time and g ambulatory time ( n = 10 for each group). * p < 0.05, ** p < 0.01

Article Snippet: Representative images of Alexa Fluor 647-conjugated RN2N administered pR5 mice at 60 min post-treatment using a Bruker In Vivo MS FX Pro optical imaging system and quantification showing the mean fluorescence counts within the outlined region of interest were reported as logarithmic scale following the subtraction of the mean of control (− IgG) ( n = 3 for each group). b Schematic of passive immunization treatment and behavioural analysis schedule in pR5 mice. c Elevated plus maze (EPM) results showing that mice treated with RN2N IgG2a spend more time in the open arms compared to the control and RN2N IgG1 treated mice.

Techniques: In Vivo, Optical Imaging, Fluorescence, Activity Assay